These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25838316)

  • 1. Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years' experience in a single, kidney disease center.
    Suzuki H; Kobayashi K; Ishida Y; Kikuta T; Inoue T; Hamada U; Okada H
    Ther Adv Cardiovasc Dis; 2015 Jun; 9(3):77-86. PubMed ID: 25838316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
    Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
    BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis.
    Sumida K; Hoshino J; Ueno T; Mise K; Hayami N; Suwabe T; Kawada M; Imafuku A; Hiramatsu R; Hasegawa E; Yamanouchi M; Sawa N; Fujii T; Ohashi K; Takaichi K; Ubara Y
    PLoS One; 2016; 11(1):e0147690. PubMed ID: 26809068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria.
    Nagai K; Yamagata K; Ohkubo R; Saito C; Asahi K; Iseki K; Kimura K; Moriyama T; Narita I; Fujimoto S; Tsuruya K; Konta T; Kondo M; Watanabe T
    Nephrology (Carlton); 2014 Sep; 19(9):574-80. PubMed ID: 24899111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis.
    Haruhara K; Tsuboi N; Kanzaki G; Koike K; Suyama M; Shimizu A; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Am J Hypertens; 2015 Sep; 28(9):1164-71. PubMed ID: 25631380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduced estimated glomerular filtration rate and proteinuria are associated with increased cardiovascular events rate in octogenarian population].
    Wang H; Dai DF; Zeng XZ; Yang JF; Liu DP; Yang JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Oct; 41(10):845-9. PubMed ID: 24377890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplified Association Between Blood Pressure and Albuminuria in Overweight Patients With Biopsy-Proven Hypertensive Nephrosclerosis.
    Kohagura K; Furuichi K; Kochi M; Shimizu M; Yuzawa Y; Hara A; Toyama T; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ubara Y; Hoshino J; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Ogawa D; Mise K; Shibagaki Y; Kimura K; Haneda M; Makino H; Matsuo S; Wada T;
    Am J Hypertens; 2019 Apr; 32(5):486-491. PubMed ID: 30689693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis.
    Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K
    J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical prognostic factors in biopsy-proven benign nephrosclerosis.
    Vikse BE; Aasarød K; Bostad L; Iversen BM
    Nephrol Dial Transplant; 2003 Mar; 18(3):517-23. PubMed ID: 12584273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    Ruilope LM; Zanchetti A; Julius S; McInnes GT; Segura J; Stolt P; Hua TA; Weber MA; Jamerson K;
    J Hypertens; 2007 Jul; 25(7):1473-9. PubMed ID: 17563571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated Glomerular Filtration Rate Within the Normal or Mildly Impaired Range and Incident Cardiovascular Disease.
    Eisen A; Hoshen M; Balicer RD; Reges O; Rabi Y; Leibowitz M; Iakobishvili Z; Hasdai D
    Am J Med; 2015 Sep; 128(9):1015-22.e2. PubMed ID: 25863153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.
    So WY; Kong AP; Ma RC; Ozaki R; Szeto CC; Chan NN; Ng V; Ho CS; Lam CW; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabetes Care; 2006 Sep; 29(9):2046-52. PubMed ID: 16936151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Benign" hypertensive nephrosclerosis.
    Dasgupta I; Porter C; Innes A; Burden R
    QJM; 2007 Feb; 100(2):113-9. PubMed ID: 17244670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-averaged proteinuria during follow-up and renal prognosis in patients with biopsy-proven benign nephrosclerosis.
    Amano H; Koike K; Haruhara K; Tsuboi N; Ogura M; Yokoo T
    Clin Exp Nephrol; 2020 Aug; 24(8):688-695. PubMed ID: 32274596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
    Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.